We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$296M
2
SMCI icon
Super Micro Computer
SMCI
+$134M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$106M
4
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$76.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$58.2M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RELY icon
2751
Remitly
RELY
$5.39B
$36.9K ﹤0.01%
1,635
-3,980
-71% -$73.3K
BPRN icon
2752
Princeton Bancorp
BPRN
$295M
$36.9K ﹤0.01%
1,071
+910
+565% +$33.4K
NVTS icon
2753
Navitas Semiconductor
NVTS
$3.57B
$36.8K ﹤0.01%
10,294
+5,726
+125% +$15.9K
DMLP icon
2754
Dorchester Minerals
DMLP
$1.35B
$36.7K ﹤0.01%
1,101
+952
+639% +$31.1K
RXRX icon
2755
Recursion Pharmaceuticals
RXRX
$1.78B
$36.7K ﹤0.01%
5,427
+616
+13% +$4.14K
VABK icon
2756
Virginia National Bankshares
VABK
$257M
$36.7K ﹤0.01%
960
+807
+527% +$33K
BV icon
2757
BrightView Holdings
BV
$1.08B
$36.6K ﹤0.01%
2,288
+1,475
+181% +$24.6K
FET icon
2758
Forum Energy Technologies
FET
$932M
$36.6K ﹤0.01%
2,360
+1,319
+127% +$19.9K
NC icon
2759
NACCO Industries
NC
$317M
$36.5K ﹤0.01%
1,225
+857
+233% +$25.4K
CBLL
2760
CeriBell Inc
CBLL
$879M
$36.5K ﹤0.01%
+1,411
New +$38.4K
MED icon
2761
Medifast
MED
$130M
$36.4K ﹤0.01%
2,068
-4,872
-70% -$90.4K
BVS icon
2762
Bioventus
BVS
$1.17B
$36.4K ﹤0.01%
3,469
+1,786
+106% +$21.1K
APO.PRA
2763
DELISTED
Apollo Global Management Series A
APO.PRA
$36.4K ﹤0.01%
419
-471
-53% -$39.5K
SABR icon
2764
Sabre
SABR
$831M
$36.4K ﹤0.01%
9,969
-8,052
-45% -$29.5K
FFWM
2765
DELISTED
First Foundation Inc
FFWM
$36.4K ﹤0.01%
5,856
-1,731
-23% -$12.5K
AVXL icon
2766
Anavex Life Sciences
AVXL
$316M
$36.3K ﹤0.01%
3,383
+1,708
+102% +$13.1K
CLFD icon
2767
Clearfield
CLFD
$395M
$36.3K ﹤0.01%
1,172
+906
+341% +$30.4K
EXFY icon
2768
Expensify
EXFY
$202M
$36.3K ﹤0.01%
10,834
+9,997
+1,194% +$26.9K
SPYU
2769
MAX S&P 500 4x Leveraged ETN
SPYU
$300M
$36.3K ﹤0.01%
1,552
-50,138
-97% -$1.25M
XLC icon
2770
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
$36.1K ﹤0.01%
373
-30,216
-99% -$2.88M
FRME icon
2771
First Merchants
FRME
$2.72B
$36.1K ﹤0.01%
905
-1,165
-56% -$47.1K
AVAH icon
2772
Aveanna Healthcare
AVAH
$2.46B
$36.1K ﹤0.01%
7,889
+6,854
+662% +$35.1K
FSP
2773
Franklin Street Properties
FSP
$46.3M
$36K ﹤0.01%
19,654
+10,674
+119% +$19.5K
BELFB
2774
Bel Fuse Inc Class B
BELFB
$4.25B
$36K ﹤0.01%
436
-4,081
-90% -$330K
ELVN icon
2775
Enliven Therapeutics
ELVN
$4.24B
$36K ﹤0.01%
1,598
+1,114
+230% +$28.9K
109 110
111
112 113

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.